Bone marrow pathology in essential thrombocythemia : interobserver reliability and utility for identifying disease subtypes. CommentaryPETERSON, Loann; WILKINS, Bridget S; CAMPBELL, Peter J et al.Blood. 2008, Vol 111, Num 1, issn 0006-4971, 1-2, 60-70 [13 p.]Article

Effectiveness of continuous glucose monitoring in pregnant women with diabetes : randomised clinical trial. CommentaryMURPHY, Helen R; RAYMAN, Gerry; LEWIS, Karen et al.BMJ. British medical journal (International ed.). 2008, Vol 337, Num 7675, pp 907-911, issn 0959-8146, 5 p.Article

JAK2 617V>F-positive polycythemia rubra vera maintained by approximately 18 stochastic stem-cell divisions per year, explaining age of onset by a single rate-limiting mutation. CommentaryCAMPBELL, Peter J; GREEN, Anthony R; VICKERS, Mark A et al.Blood. 2007, Vol 110, Num 5, issn 0006-4971, 1409, 1675-1680 [7 p.]Article

Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomesMCBRIDE, David J; ETEMADMOGHADAM, Dariush; LAU, King W et al.Journal of pathology (Print). 2012, Vol 227, Num 4, pp 446-455, issn 0022-3417, 10 p.Article

The cancer genomeSTRATTON, Michael R; CAMPBELL, Peter J; FUTREAL, P. Andrew et al.Nature (London). 2009, Vol 458, Num 7239, pp 719-724, issn 0028-0836, 6 p.Article

MPL mutations in myeloproliferative disorders : analysis of the PT-1 cohortBEER, Philip A; CAMPBELL, Peter J; WHEATLEY, Keith et al.Blood. 2008, Vol 112, Num 1, pp 141-149, issn 0006-4971, 9 p.Article

Essential thrombocythemia beyond the first decade : Life expectancy, long-term complication rates, and prognostic factorsCAMPBELL, Peter J; GREEN, Anthony R; WOLANSKYJ, Alexandra P et al.Mayo Clinic proceedings. 2006, Vol 81, Num 2, pp 157-158, issn 0025-6196, 10 p.Article

How I treat essential thrombocythemiaBEER, Philip A; ERBER, Wendy N; CAMPBELL, Peter J et al.Blood. 2011, Vol 117, Num 5, pp 1472-1482, issn 0006-4971, 11 p.Article

A comprehensive catalogue of somatic mutations from a human cancer genomePLEASANCE, Erin D; CHEETHAM, R. Keira; KAI YE et al.Nature (London). 2010, Vol 463, Num 7278, pp 191-196, issn 0028-0836, 6 p.Article

Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genesDALGLIESH, Gillian L; FURGE, Kyle; TEAGUE, Jon et al.Nature (London). 2010, Vol 463, Num 7279, pp 360-363, issn 0028-0836, 4 p.Article

Reliability of the long caseWILKINSON, Tim J; CAMPBELL, Peter J; JUDD, Stephen J et al.Medical education (Oxford. Print). 2008, Vol 42, Num 9, pp 887-893, issn 0308-0110, 7 p.Article

Mutation of JAK2 in the myeloproliferative disorders : timing, clonality studies, cytogenetic associations, and role in leukemic transformationCAMPBELL, Peter J; BAXTER, E. Joanna; LE BOUSSE-KERDILES, Marie-Caroline et al.Blood. 2006, Vol 108, Num 10, pp 3548-3555, issn 0006-4971, 8 p.Article

Modelling a minimal residual disease-based treatment strategy in childhood acute lymphoblastic leukaemiaCAMPBELL, Peter J; MORLEY, Alexander A.British journal of haematology. 2003, Vol 122, Num 1, pp 30-38, issn 0007-1048, 9 p.Article

Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohortCAMPBELL, Peter J; MACLEAN, Cathy; BEER, Philip A et al.Blood. 2012, Vol 120, Num 7, pp 1409-1411, issn 0006-4971, 3 p.Article

Evolution of the cancer genomeYATES, Lucy R; CAMPBELL, Peter J.Nature reviews. Genetics (Print). 2012, Vol 13, Num 11, pp 795-806, issn 1471-0056, 12 p.Article

JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subcloneGODFREY, Anna L; CHEN, Edwin; BIJOU, Fontanet et al.Blood. 2012, Vol 120, Num 13, pp 2704-2707, issn 0006-4971, 4 p.Article

The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasmsJONES, Amy V; CAMPBELL, Peter J; SILVER, Richard T et al.Blood. 2010, Vol 115, Num 22, pp 4517-4523, issn 0006-4971, 7 p.Article

Reticulin Accumulation in Essential Thrombocythemia: Prognostic Significance and Relationship to TherapyCAMPBELL, Peter J; BAREFORD, David; ERBER, Wendy N et al.Journal of clinical oncology. 2009, Vol 27, Num 18, pp 2991-2999, issn 0732-183X, 9 p.Article

An acquired translocation in JAK2 Val617Phe-negative essential thrombocythemia associated with autosomal spread of X-inactivationVASSILIOU, George S; CAMPBELL, Peter J; SCOTT, Linda M et al.Haematologica (Roma). 2006, Vol 91, Num 8, pp 1100-1104, issn 0390-6078, 5 p.Article

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersBAXTER, E. Joanna; SCOTT, Linda M; SCOTT, Mike A et al.Lancet (British edition). 2005, Vol 365, Num 9464, pp 1054-1061, issn 0140-6736, 8 p.Article

The landscape of cancer genes and mutational processes in breast cancerSTEPHENS, Philip J; TARPEY, Patrick S; YATES, Lucy R et al.Nature (London). 2012, Vol 486, Num 7403, pp 400-404, issn 0028-0836, 5 p.Article

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasmsMALCOVATI, Luca; PAPAEMMANUIL, Elli; GALLI, Anna et al.Blood. 2011, Vol 118, Num 24, pp 6239-6246, issn 0006-4971, 8 p.Article

Comparison of different criteria for the diagnosis of primary myelofibrosis reveals limited clinical utility for measurement of serum lactate dehydrogenaseBEER, Philip A; CAMPBELL, Peter J; GREEN, Anthony R et al.Haematologica (Roma). 2010, Vol 95, Num 11, pp 1960-1963, issn 0390-6078, 4 p.Article

Somatic mutations of the histone H3K27 demethylase gene UTX in human cancerVAN HAAFTEN, Gijs; DALGLIESH, Gillian L; BUTLER, Adam et al.Nature genetics. 2009, Vol 41, Num 5, pp 521-523, issn 1061-4036, 3 p.Article

Complex landscapes of somatic rearrangement in human breast cancer genomesSTEPHENS, Philip J; MCBRIDE, David J; GREENMAN, Chris D et al.Nature (London). 2009, Vol 462, Num 7276, pp 1005-1010, issn 0028-0836, 6 p.Article